Literature DB >> 27270495

Isolation and characterization of primary bone marrow mesenchymal stromal cells.

Hongzhe Li1, Roshanak Ghazanfari1, Dimitra Zacharaki1, Hooi Ching Lim1, Stefan Scheding1,2.   

Abstract

Bone marrow (BM) contains a rare population of mesenchymal stromal cells (MSCs), which have been characterized as nonhematopoietic skeletal progenitor cells with central importance for the hematopoietic microenvironment. Classically, MSCs are isolated by plastic adherence and subsequent culture. However, as cultured stromal cells differ from their in vivo progenitors, it is important to identify the phenotype of the primary MSCs to study these cells in more detail. In the past years, several surface markers have been reported to be suitable for effective enrichment of BM-MSCs, and recent data indicate that the putative MSC stem/progenitor cell population in human adult BM is highly enriched in Lin(-) CD45(-) CD271(+) CD140a (PDGFRα)(low/-) cells. Moreover, surface marker combinations have been described for the isolation of MSCs from murine BM. On the basis of these findings, the role of primary MSCs can now be studied in normal and, importantly, diseased BM. Furthermore, genetically engineered mouse models have been developed as powerful tools to investigate well-defined BM stromal cell populations in vivo. Our discussion aims to provide a concise overview of the current state of the art in BM-MSC isolation in humans and briefly present murine MSC isolation approaches and genetic models.
© 2016 The Authors. Annals of the New York Academy of Sciences published by Wiley Periodicals Inc. on behalf of The New York Academy of Sciences.

Entities:  

Keywords:  CD271; CFU-F; MSC; PDGFRα; bone marrow; bone marrow stromal cells; mesenchymal stromal cells

Mesh:

Substances:

Year:  2016        PMID: 27270495     DOI: 10.1111/nyas.13102

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  50 in total

1.  Bone marrow mesenchymal stem cell co-adjuvant therapy with albendazole for managing Toxocara vitulorum-rat model.

Authors:  Faten A M Abo-Aziza; Abdel Kader A Zaki; Ahmed I Alajaji; Saleh M Al Barrak
Journal:  Vet World       Date:  2021-02-08

2.  LncRNA RAD51-AS1 Regulates Human Bone Marrow Mesenchymal Stem Cells via Interaction with YBX1 to Ameliorate Osteoporosis.

Authors:  Beichen Li; Jing Wang; Fangrong Xu; Qinjue Wang; Quan Liu; Guantong Wang; Dengshun Miao; Qiang Sun
Journal:  Stem Cell Rev Rep       Date:  2022-06-21       Impact factor: 5.739

3.  Correlation Between CD133+ Stem Cells and Clinical Improvement in Patients with Autism Spectrum Disorders Treated with Intrathecal Bone Marrow-derived Mononuclear Cells.

Authors:  Laura Villarreal-Martinez; Laura Elia MartÍnez-Garza; Iram Pablo Rodriguez-Sanchez; Neri Alvarez-Villalobos; Fernando Guzman-Gallardo; Sulia Pope-Salazar; Cynthia Salinas-Silva; Maria Guadalupe Cepeda-Cepeda; Alejandra Garza-Bedolla; Irving Armando Dominguez-Varela; Daniel Zacarias Villarreal-Martinez; Jose Humberto Treviño-Villarreal; David Gomez-Almaguer
Journal:  Innov Clin Neurosci       Date:  2022 Apr-Jun

Review 4.  Native joint-resident mesenchymal stem cells for cartilage repair in osteoarthritis.

Authors:  Dennis McGonagle; Thomas G Baboolal; Elena Jones
Journal:  Nat Rev Rheumatol       Date:  2017-11-09       Impact factor: 20.543

5.  Comparison of the Chondrogenic Potential of Mesenchymal Stem Cells Derived from Bone Marrow and Umbilical Cord Blood Intended for Cartilage Tissue Engineering.

Authors:  Romain Contentin; Magali Demoor; Miranda Concari; Mélanie Desancé; Fabrice Audigié; Thomas Branly; Philippe Galéra
Journal:  Stem Cell Rev Rep       Date:  2020-02       Impact factor: 5.739

Review 6.  Stem cell therapy in discogenic back pain.

Authors:  Ahmed H Barakat; Vivian A Elwell; Khai S Lam
Journal:  J Spine Surg       Date:  2019-12

7.  [Clinical research progress of mesenchymal stem cells in treatment of chronic wounds].

Authors:  Yingxuan Cao; Jianxin Yan; Hongwei Liu
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-04-15

8.  CD73+ Mesenchymal Stem Cells Ameliorate Myocardial Infarction by Promoting Angiogenesis.

Authors:  Qiong Li; Huifang Hou; Meng Li; Xia Yu; Hongbo Zuo; Jianhui Gao; Min Zhang; Zongjin Li; Zhikun Guo
Journal:  Front Cell Dev Biol       Date:  2021-05-12

Review 9.  Nerve growth factor (NGF) and NGF receptors in mesenchymal stem/stromal cells: Impact on potential therapies.

Authors:  Kangkang Zha; Yu Yang; Guangzhao Tian; Zhiqiang Sun; Zhen Yang; Xu Li; Xiang Sui; Shuyun Liu; Jinmin Zhao; Quanyi Guo
Journal:  Stem Cells Transl Med       Date:  2021-02-15       Impact factor: 6.940

Review 10.  Bone Marrow Multipotent Mesenchymal Stromal Cells as Autologous Therapy for Osteonecrosis: Effects of Age and Underlying Causes.

Authors:  Jehan J El-Jawhari; Payal Ganguly; Elena Jones; Peter V Giannoudis
Journal:  Bioengineering (Basel)       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.